ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP. Tarantino, G. Curigliano, Frédérique Penault‐Llorca et al.|Annals of Oncology|2023Cited by 298
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsNiklas Gremke, Thorsten Stiewe, Isabelle Besong et al.|Signal Transduction and Targeted Therapy|2025Cited by 19